Translocations involving c-myc and c-myc function

被引:361
作者
Boxer, LM
Dang, CV
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA
关键词
c-myc; gene expression; lymphoma; apoptosis;
D O I
10.1038/sj.onc.1204595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-MYC is the prototype for oncogene activation by chromosomal translocation. In contrast to the tightly regulated expression of c-myc in normal cells, c-myc is frequently deregulated in human cancers. Herein, aspects of c-myc gene activation and the function of the c-Myc protein are reviewed. The c-myc gene produces an oncogenic transcription factor that affects diverse cellular processes involved in cell growth, cell proliferation, apoptosis and cellular metabolism. Complete removal of c-myc results in slowed cell growth and proliferation, suggesting that while c-myc is not required for cell proliferation, it acts as an integrator and accelerator of cellular metabolism and proliferation.
引用
收藏
页码:5595 / 5610
页数:16
相关论文
共 189 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]   Cyclin E and c-Myc promote cell proliferation in the presence of p16(INK4a) and of hypophosphorylated retinoblastoma family proteins [J].
Alevizopoulos, K ;
Vlach, J ;
Hennecke, S ;
Amati, B .
EMBO JOURNAL, 1997, 16 (17) :5322-5333
[3]  
Amati B., 1998, FRONT BIOSCI, V3, pd250, DOI DOI 10.2741/A239
[4]   Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents [J].
Amundson, SA ;
Zhan, Q ;
Penn, LZ ;
Fornace, AJ .
ONCOGENE, 1998, 17 (17) :2149-2154
[5]  
ARCINAS M, 1994, ONCOGENE, V9, P2699
[6]   DIFFERENTIAL EXPRESSION OF THE TRANSLOCATED AND THE UNTRANSLOCATED C-MYC ONCOGENE IN BURKITT-LYMPHOMA [J].
ARRUSHDI, A ;
NISHIKURA, K ;
ERIKSON, J ;
WATT, R ;
ROVERA, G ;
CROCE, CM .
SCIENCE, 1983, 222 (4622) :390-393
[7]  
ASKEW DS, 1991, ONCOGENE, V6, P1915
[8]  
Ayer DE, 1996, MOL CELL BIOL, V16, P5772
[9]   MAD - A HETERODIMERIC PARTNER FOR MAX THAT ANTAGONIZES MYC TRANSCRIPTIONAL ACTIVITY [J].
AYER, DE ;
KRETZNER, L ;
EISENMAN, RN .
CELL, 1993, 72 (02) :211-222
[10]   c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].
Bahram, F ;
von der Lehr, N ;
Cetinkaya, C ;
Larsson, LG .
BLOOD, 2000, 95 (06) :2104-2110